StonvexLoading…
StonvexStonvexStonvexCore line items from TCRX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $10.32M | $2.82M | $21.05M | $13.54M |
Operating Income | $-135.81M | $-134.82M | $-93.46M | $-66.64M |
Net Income | $-129.77M | $-127.50M | $-89.22M | $-66.22M |
EPS (Diluted) | $-1.00 | $-1.14 | $-1.36 | $-2.75 |
Total Assets | $228.79M | $371.12M | $272.15M | $199.09M |
Total Liabilities | $105.67M | $130.15M | $121.28M | $99.66M |
Cash & Equivalents | $152.41M | $178.69M | $133.36M | $120.03M |
Free Cash Flow OCF − CapEx | $-139.73M | $-114.65M | $-64.50M | $-70.73M |
Shares Outstanding | 129.78M | 111.99M | 65.60M | 24.05M |